**Core tip:** In human gastric epithelial cells, NKX6.3 depletion induced production of amyloid β (Aβ) oligomers, and also increased expression of apolipoprotein E (ApoE), Aβ, β-secretase 1 (Bace1), nicastrin, and receptor for advanced glycosylation end product proteins. Moreover, NKX6.3 depletion leads to stably formed of γ-secretase complex and binding to Bace1 protein. In gastric mucosae with atrophy, expression of Aβ oligomer, ApoE, and Bace1 was detected and inversely correlated with NKX6.3 expression. Additionally, treatment with recombinant Aβ 1-42 produced oligomeric forms of Aβ and significantly decreased cell viability in NKX6.3 depleting cells. These observations provide evidences that NKX6.3 can inhibit gastric mucosal atrophy by regulating Aβ peptide accumulation and inflammatory reaction in gastric epithelial cells.

INTRODUCTION
============

Atrophic gastritis is characterized by loss of appropriate glands and reduction in gastric secretory function due to chronic inflammatory processes in gastric mucosa\[[@B1]\]. In South Korea, the prevalence of atrophic gastritis is relatively high. It is 59.4% in people older than 60 years\[[@B2]\], and the crude incidence for cancer is 1.7% in atrophic gastritis\[[@B3]\]. It has been widely accepted that chronic inflammation of the stomach can initiate histopathologic progression from chronic gastritis to gastric atrophy, intestinal metaplasia, dysplasia and finally gastric cancer\[[@B4]-[@B6]\]. Thus, atrophic gastritis is considered as a precancerous condition of gastric cancer. However, little is known about the molecular mechanism underlying gastric mucosal atrophy and its contribution to gastric carcinogenesis.

Amyloid β peptide (Aβ) plays a key role in pathogenesis of Alzheimer's disease. It is a 4-kDa metalloprotein with 39- to 43-amino acids derived from proteolytic cleavage of amyloid precursor protein (APP) by β- and γ-secretase\[[@B7]\]. In contrast, α-secretase ADAM10, a metalloprotease, cleaves APP within the Aβ domain, thus preventing Aβ generation\[[@B8]\]. It has been reported that β-site amyloid precursor protein cleaving enzyme (BACE) is a novel transmembrane aspartic protease that exhibits properties of β-secretase\[[@B9]\]. γ-secretase is a high molecular weight complex minimally composed of four components: presenilin (PS), nicastrin (NCT), anterior pharynx-defective-1 (APH-1), and presenilin enhancer-2 (PEN2)\[[@B10]-[@B13]\]. BACE1 cleaves APP not processed by α-secretase to generate carboxy-terminal fragments of 99 amino acids. This is further processed by γ-secretase to Aβ40 and Aβ42 that are transported to the cell surface which they are secreted *via* recycling vesicle\[[@B14]\]. In addition, receptor for advanced glycation end products (RAGE) is one of receptors that medicate Aβ effects on neurons and microglia\[[@B15]\] and is implicated in a wide spectrum of pathological responses, including inflammation and cancer\[[@B16]\]. Apolipoprotein E (ApoE) increases oligomerization of Aβ peptide in an isoform-dependent manner\[[@B17]\] and major ApoE receptors belong to low-density lipoprotein (LDL) receptor family\[[@B18]\]. It has been proposed that accumulated Aβ proteins can generate oligomers and induce synaptic dysfunction and death of neurons\[[@B19],[@B20]\].

NKX family of homeodomain transcription factors are involved in a variety of developmental processes, and the NKX6.3 member is expressed in epithelium of the most distal stomach\[[@B21],[@B22]\]. Previously, we have reported that NKX6.3 functions as a master regulator of gastric differentiation by modulating SOX2 and CDX2 expression and as a tumor suppressor by inhibiting cell proliferation and inducing apoptosis\[[@B23],[@B24]\]. Interestingly, gastric tumor suppressor gastrokine 1 (GKN1), a downstream target of NKX6.3, interacts with APP and inhibits polymerization of Aβ\[[@B25],[@B26]\]. Thus, we hypothesized that transcription factor NKX6.3 might be involved in maintaining gastric epithelial homeostasis by regulating Aβ production. Here, we provide the first evidence that NKX6.3 may protect gastric mucosal epithelial cells from atrophy by inhibiting Aβ production and polymerization.

MATERIALS AND METHODS
=====================

Samples
-------

A total of 55 patients with sporadic gastric cancer who underwent a gastrectomy at Chonnam National University Hwasun Hospital were included. Fresh-frozen non-neoplastic gastric mucosae remote (≥ 5 cm) from the tumor were used in this study. In addition, gastric mucosal tissues adjacent to each frozen specimen were fixed in formalin and stained with hematoxylin-eosin. Patients with a history of familial gastric cancer were excluded. Two expert gastrointestinal pathologists independently assessed the histologic specimens according to the updated Sydney system and the reached a consensus for all specimens\[[@B27]\]. Atrophy was defined as loss of appropriate glands and a periodic acid Schiff staining was used to identify intestinal metaplasia. Gastric mucosae with atrophy and intestinal metaplasia were considered as atrophic gastritis. The presence of *Helicobacter pylori* (*H. pylori*) CagA was determined by Western blot analysis\[[@B28]\]. This study was approved by the Institutional Review Board (IRB) of The Catholic University of Korea, College of Medicine (approval number: MC16SISI0130).

Cell culture and transfection of NKX6.3
---------------------------------------

HFE-145 immortalized gastric epithelial cell line expressing NKX6.3 was cultured at 37 °C and 5% CO~2~ in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum. shNKX6.3 was cloned into pSilencer 3.1 H1-neo (Invitrogen, Carlsbad, CA, United States). We generated stable shNKX6.3 transfectants of HFE-145 cells (HFE-145^shNKX6.3^ cells), stably silencing human NKX6.3 expression, as well as shControl transfectants of HFE-145^shCtrl^ cells as described previously\[[@B24]\]. Expression levels of NKX6.3 in HFE-145^shCtrl^ and HFE-145^shNKX6.3^ cells were confirmed by Western blot analysis. The *CagA* gene of *H. pylori* was cloned into a pSP65SRalpha vector containing a hemagglutinin (HA) tag, and the HFE-145 cells were transfected with *CagA* gene, as described previously\[[@B24]\]. The *CagA* construct was kindly provided by Dr. Hatakeyama (Tokyo University, Tokyo, Japan).

Cell count of floating and adherent cells
-----------------------------------------

HFE-145^shCtrl^ and HFE-145^shNKX6.3^ cells in complete medium were seeded onto 12-well plates at a density of 1 × 10^4^ cells per well. Floating and adherent cells were harvested after 48 h of culture and counted using a hemocytometer.

Cell viability and proliferation assay
--------------------------------------

For cell viability analysis, MTT assay were performed for HFE-145 immortalized gastric epithelial cells at 24, 48, 72, and 96 h after treatment with recombinant Aβ (1 μg/mL, rAβ, Sigma, St. Louis, MO, United States). Absorbance at 540 nm was measured using a spectrophotometer and cell viability was expressed relative to non-treated cells.

Measurement of caspase 3/7 activity
-----------------------------------

To analyze the effect of NKX6.3 on apoptosis, caspase-3 and -7 activities were examined using an Apo-One Homogeneous caspase 3/7 assay kit (Promega Corporation, Madison, WI, United States) as described previously\[[@B28]\].

Measurement of NKX6.3, ApoE, Bace1, and inflammatory cytokine expression
------------------------------------------------------------------------

Expression levels of *NKX6.3*, *ApoE*, and *Bace1* mRNA transcripts were examined in 55 gastric mucosal tissues by real-time RT-PCR. In addition, to investigate whether ablation of NKX6.3 might contributed to inflammatory cytokine expression, the expression of *IL-1β*, *IL-6*, *IL-8*, and *COX-2* mRNAs in HFE-145^shCtrl^ and HFE-145^shNKX6.3^ cells were analyzed by real-time RT-PCR. The effects of *ApoE* silencing with *siApoE* on expression levels of inflammatory cytokines were also examined. After quantification of total RNA extracted from 55 frozen gastric mucosal tissues, HFE-145^shCtrl^, and HFE-145^shNKX6.3^ cells, RT-PCR was carried out using SYBR Green Q-PCR Master Mix (Bio-Rad, Hercules, CA, United States) according to the manufacturer's protocol. The mRNA expression of these genes was quantified by quantitative real-time reverse transcription PCR (QRT-PCR) and normalized to mRNA level of *β-actin*. Primer sequences are presented in Supplementary Table 1. Data are reported as relative quantities according to an internal calibrator using a 2^-ΔΔCT^ method\[[@B23]\]. The standard curve method was used for quantification of the relative amounts of gene expression products. This method provides unit-less normalized expression values that can be used for direct comparison of the relative amount of RNA in different samples.

Immunoblot and immunofluorescent studies
----------------------------------------

Primary anti-Aβ antibody (Merck-millipore, Darmstadt, Germany), anti-BACE1 (Abcam, Cambridge, United Kingdom) and secondary anti-alexa-488 conjugated goat anti-mouse IgG antibody (Invitrogen, CA, United States) were used to visualize immunoreactivity. The specificity of reactions was tested by incubation with non-immune mouse serum (Invitrogen).

We examined expression levels of NKX6.3 and Aβ-related genes in cell lysates by Western blot analysis. We separated equal amounts of cell lysates by 12.5% SDS-PAGE and transferred them to Hybond-polyvinylidene difluoride transfer membranes (Amersham Biosciences, NJ, United States). After blocking with 0.5% skim milk, we blotted the membranes with the primary antibodies and then incubated them with horseradish peroxidase-conjugated secondary antibodies. We detected the protein bands using westernsure ECL substrate (LI-COR Biosciences, NE, United States) and visualized the intensity of bands using a LAS 4000 image analyzer (Fuji Film, Japan). The antibody list is described in Supplementary Table 2.

Chromatin immunoprecipitation assay
-----------------------------------

For assessing the NKX6.3 binding activity to the promoter regions of *ApoE* and *Bace1*, chromatin immunoprecipitation (ChIP) assays were performed using the Thermo Scientific Pierce Agarose ChIP kit (Thermo Scientific Pierce, Rockford, IL, United States), as previously described\[[@B24]\]. Briefly, HFE-145^shCtrl^ and HFE-145^shNKX6.3^ cells were cultured in a 10-cm dish for 4 d. The cells were fixed with 1% formaldehyde in PBS for 10 min, washed twice with ice-cold PBS and re-suspended in lysis buffer. Nuclei were recovered by centrifugation and MNase digestion was carried out at 37 °C for 15 min. Nuclei were lysed and the extracts were immunoprecipitated with 4 μg of antibody against NKX6.3 at 4 °C overnight. Normal rabbit IgG was used as a negative control. Protein-bound DNA was recovered using affinity chromatography purification columns according to the manufacturer's protocol (Thermo Scientific), and 5 μL of lysed nuclei were also purified under the same procedure and used as input. DNA amplification was performed by PCR using primers for the *ApoE* and *Bace1* promoters described in Supplementary Table 1. Amplification products were separated on a 2% agarose gel.

Aβ ELISAs
---------

ELISAs for measuring Aβ42 peptide were performed using commercial kits (Invitrogen) following the manufacturer's instructions. Briefly, Aβ42 ELISAs were performed using 6E10 as a capture antibody and anti-Aβ42 HRP-conjugated antibodies (Covance, Dedham, MA, United States) as detection antibodies. Synthetic Aβ42 were used to generate a standard curve for each experiment. The plates were developed using TMB substrate kit (Pierce, Rockford, IL, United States) and the reaction was stopped by addition of equal volume of 1 mol/L HCl. The results were read using a Spectramax colorimetric plate reader (Molecular Devices, Sunnyvale, CA, United States).

Immunoprecipitation
-------------------

For coimmunoprecipitation experiments, cells were harvested in PBS, centrifuged at 800 g for 10 min, and lysed in 125 mmol/L NaCl, 50 mmol/L Hepes, pH 7.4 (supplemented with 1% Triton X-100 or CHAPS and Complete protease inhibitors) for 30 min at 4 °C. After centrifugation at 16000 g for 15 min, cleared cell extracts were incubated overnight at 4 °C with protein A/G-agarose (Santa Cruz Biotechnology, Santa Cruz, CA, United States) and anti-PSN1 or anti-rabbit IgG beads. Immunoprecipitated proteins were resolved on 12% SDS-polyacrylamide gels and transferred to PVDF membranes (Bio-Rad, Richmond, CA, United States). The membranes were blocked for 1 h in PBS containing 0.1% Tween 20 (PBS-T) and 5% non-fat dry milk (Sigma) and reacted with antibodies against PSN1, each diluted 1:1000. The membranes were washed with PBS-T, then incubated for 1 h at room temperature with horseradish peroxidase-conjugated anti-rabbit IgG antibody (Sigma), diluted 1:5000, and developed with westernsure ECL substrate (LI-COR Biosciences). Immunoreactive bands were identified by co-migration of prestained protein size markers (Fermentas, Glen Burnie, MD, United States). To confirm equivalent protein loading and transfer, the blots were stripped and re-probed for GAPDH (Santa Cruz Biotechnology).

Statistical analyses
--------------------

Pearson and Student's *t*-tests were used to analyze the correlation between expression of NKX6.3, GKN1, Aβ peptide oligomer, ApoE, and BACE1. We performed all experiments in duplicate to verify the reproducibility of the findings. Data are expressed as means ± SD from two independent experiments. A *P*-value \< 0.05 was considered to be the limit of statistical significance.

RESULTS
=======

Loss of NKX6.3 expression induces both cell death and proliferation
-------------------------------------------------------------------

During cell culture, NKX6.3 depletion in HFE-145^shNKX6.3^ cells increased populations of both adherent and floating cells compared to HFE-145^shCtrl^ cells (Figure [1A](#F1){ref-type="fig"}). Since previously we have reported that NKX6.3 depletion increases cell population of HFE-145 cells\[[@B24]\], here we focused on the increase of floating HFE-145^shNKX6.3^ cells. When we examined the effects of NKX6.3 depletion on cell death, caspase 3/7 activity was significantly increased only in floating HFE-145^shNKX6.3^ cells (Figure [1B](#F1){ref-type="fig"}). Interestingly, NKX6.3 depletion did not affect expression of apoptosis markers including caspase-3, -9, and PARP in attached cells. However, expression levels of cleaved forms of caspase-3, -9, and PARP were increased in floating HFE-145^shNKX6.3^ cells compared with those in floating HFE-145^shCtrl^ cells (Figure [1C](#F1){ref-type="fig"}). Thus, it is likely that NKX6.3 may inhibit both cell proliferation and apoptotic cell death in gastric epithelial cells.

![NKX6.3 inhibits both cell proliferation and apoptotic cell death in gastric epithelial cells. A: NKX6.3 depletion in HFE-145^shNKX6.3^ cells increased both adherent and floating cell populations. Shown are the means ± SEM from three experiments. Superscript letter represents significant difference (^a^*P \<* 0.005). B: Caspase 3/7 activity was significantly increased in floating HFE-145^shNKX6.3^ cells. Shown are the means ± SEM from three experiments. Superscript letter significant difference (^b^*P \<* 0.0001). C: In Western blot analysis, expression of cleaved forms of caspase-3, -9, and poly ADP ribose polymerase (PARP) was increased in floating HFE-145^shNKX6.3^ cells.](WJG-25-330-g001){#F1}

NKX6.3 inhibits Aβ accumulation by regulating ApoE, β-, and γ-secretase
-----------------------------------------------------------------------

Next, we examined whether NKX6.3 was involved in Aβ production in HFE-145 cells. Interestingly, NKX6.3 depletion markedly induced expression of ApoE, APP, Aβ peptide, BACE1, LDLR, NCT, high-mobility group box 1 (HMGB1), and RAGE proteins but decreased expression of presenilin1 (PSN1) protein in HFE-145 cells (Figure [2A](#F2){ref-type="fig"}). There are three distinct pools of Aβ species: monomers, soluble oligomers, and insoluble fibrils\[[@B29]\]. Interestingly, HFE-145^shCtrl^ cells only expressed Aβ monomer, while NKX6.3 depleted HFE-145^shNKX6.3^ cells induced production of Aβ oligomers and increased expression of Aβ monomer (Figure [2A](#F2){ref-type="fig"}). When we examined the effect of NKX6.3 on γ-secretase assembly by immunoprecipitation assay, γ-secretase complex, including PSN1, PSN2, NCT, and PEN2 was stably formed and binding to BACE1 protein only in NKX6.3 depleted HFE-145^shNKX6.3^ cells (Figure [2B](#F2){ref-type="fig"}). In immunofluorescence analysis, strong expression of Aβ peptides were detected in the cytoplasm of NKX6.3 depleted HFE-145^shNKX6.3^ cells (Figure [2C](#F2){ref-type="fig"}). Notably, aggregated Aβ peptide was not detected in HFE-145^shCtrl^ cells expressing NKX6.3 whereas NKX6.3 depletion significantly increased concentrations of the aggregated Aβ peptide in both cell lysate and culture media (Figure [2D](#F2){ref-type="fig"}). In NKX6.3 depleted HFE-145^shNKX6.3^ cells, mRNA expression of *ApoE* and *Bace1* genes were significantly increased (Figure [2E](#F2){ref-type="fig"}) while binding capacity of NKX6.3 to promoter regions of *ApoE* and *Bace1* genes was dramatically decreased in ChIP assay (Figure [2F](#F2){ref-type="fig"}), suggesting that NKX6.3 might be a transcriptional repressor of *ApoE* and *Bace1* genes. When we treated HFE-145^shCtrl^ and HFE-145^shNKX6.3^ cells with recombinant Aβ 1-42 (rAβ 1-42), ApoE and oligomeric forms of Aβ were detected in NKX6.3 depleted HFE-145^shNKX6.3^ cells (Figure [2G](#F2){ref-type="fig"}). Taken together, these results suggest that NKX6.3 may inhibit accumulation and oligomerization of Aβ peptide in gastric epithelial cells.

![NKX6.3 inhibits amyloid β accumulation by regulating apolipoprotein E, β-, and γ-secretase. A: Western blot analysis showing increased expression of apolipoprotein E (ApoE), amyloid precursor protein (APP), amyloid β (Aβ), β-secretase 1 (Bace1), low-density lipoprotein receptor (LDLR), nicastrin (NCT), high mobility group box1 (HMGB1), and receptor for advanced glycosylation end product (RAGE) proteins but decreased expression of presenilin 1 (PSN1)- C-terminal (CTF) protein in NKX6.3 depleted HFE-145 cells. Interestingly, HFE-145^shCtrl^ cells expressed only Aβ monomer whereas NKX6.3 depleted HFE-145^shNKX6.3^ cells induced production of oligomers of Aβ and increased expression of Aβ monomer. B: In immunoprecipitation assay, γ-secretase complex including PSN1-CTF and 2-CTF, NCT, and presenilin enhancer 2 (PEN2) was stably formed, binding to Bace1 protein only in NKX6.3 depleted HFE-145^shNKX6.3^ cells. C: Immunofluorescence images showing strong expression of Aβ protein in the cytoplasm of NKX6.3 depleted HFE-145^shNKX6.3^ cells. D: In Aβ42 enzyme-linked immunosorbent assay, NKX6.3 depletion significantly increased concentrations of aggregated Aβ in both cell lysate and culture media. Shown are the means ± SEM from three experiments. Superscript letter significant difference (^a^*P* \< 0.0001). E: Increased mRNA expression of *ApoE* and *Bace1* genes was detected in NKX6.3 depleted HFE-145^shNKX6.3^ cells. Shown are the means ± SEM from three experiments. Superscript letter represents significant difference (^b^*P \<* 0.005 and ^c^*P* \< 0.0001). F: In chromatin immunoprecipitation assay, the binding capacity of NKX6.3 to promoter regions of *ApoE* and *Bace1* genes was dramatically decreased. Shown are the means ± SEM from three experiments. Superscript letter represents significant difference (^d^*P \<* 0.005 and ^e^*P* \< 0.0001). G: When we treated HFE-145^shCtrl^ and HFE-145^shNKX6.3^ cells with Aβ 1-42 recombinant protein (rAβ 1-42), expression levels of ApoE and oligomeric forms of Aβ were makedly increased in NKX6.3 depleted HFE-145^shNKX6.3^ cells. CHAP: Chaps buffer; TX: Triton-100; ApoE: Apolipoprotein E; APP: Amyloid precursor protein; Aβ: Amyloid β; Bace1: β-secretase 1; LDLR: Low-density lipoprotein receptor; NCT: Nicastrin; HMGB1: High mobility group box1; RAGE: Receptor for advanced glycosylation end product; PSN1: Presenilin 1; CTF: C-terminal; PEN2: Presenilin enhancer 2; rAβ 1-42: Aβ 1-42 recombinant protein.](WJG-25-330-g002){#F2}

Aβ oligomerization is strongly associated with gastric mucosal atrophy
----------------------------------------------------------------------

Histologically, gastric mucosal atrophy was found in 18 (32.7%) of 55 gastric mucosae. In Western blot analysis, Aβ oligomers, including tetramer, were mainly expressed in gastric mucosae with atrophy. In addition, expression levels of ApoE, Bace1, and cleaved form of caspase-3 were increased in atrophic gastric mucosae along with reduced NKX6.3 expression (Figure [3A](#F3){ref-type="fig"}). To further confirm the effect of NKX6.3 on ApoE and Bace1 expression, we compared expression levels of *NKX6.3* with *ApoE* and *Bace1* mRNA expression levels in 55 non-neoplastic gastric mucosae by real-time RT-PCR. Previously, NKX6.3 expression has been found to be significantly reduced in the cases with atrophy\[[@B23]\]. As expected, mRNA expression levels of *ApoE* and *Bace1* were significantly higher in gastric mucosae with atrophy (Figure [3B](#F3){ref-type="fig"}), showing inverse correlations with *NKX6.3* expression (*P* = 0.0001) (Figure [3C](#F3){ref-type="fig"}). In addition, reduced expression of NKX6.3 protein, expression of Aβ oligomer, Bace1, ApoE, and cleaved caspase-3 proteins, and CagA were significantly associated with gastric mucosal atrophy. The expression of Aβ oligomer was positively correlated with expression of Bace1, ApoE, cleaved caspase-3, and CagA (Figure [3D](#F3){ref-type="fig"}). We also measured aggregated Aβ peptide concentrations in 55 gastric mucosae by ELISA and found significantly higher Aβ peptide concentrations in gastric mucosae with atrophy (1.20 ± 0.60 μg/mL) than those in gastric mucosae without atrophy (0.09 ± 0.09 μg/mL; Figure [3E](#F3){ref-type="fig"}). When we transfected HFE-145 cells with CagA, ectopic expression of CagA reduced the expression of NKX6.3 but increased Aβ oligomerization and expression of ApoE, Bace1, and cleaved caspase-3 (Figure [3F](#F3){ref-type="fig"}). Next, we examined Aβ oligomer expression in 6 non-neoplastic gastric mucosae with atrophy (*n* = 3) and without atrophy (*n* = 3) using specific antibody against Aβ oligomer by immunofluorescent assay. Consistent with above result, expression of Aβ oligomer was detected in gastric mucosae with atrophy in immunofluorescent assay (Figure [3G](#F3){ref-type="fig"}). Interestingly, Aβ oligomer was present only in gastric mucosal epithelial cells, but not in extracellular matrix including inflammatory cells (Figure [3G](#F3){ref-type="fig"}).

![Amyloid β oligomerization is strongly associated with gastric mucosal atrophy. A: In Western blot analysis, amyloid β (Aβ) oligomers were expressed only in gastric mucosae with atrophy. Expression of apolipoprotein E (ApoE), β-secretase 1 (Bace1), and cleaved form of caspase-3 were increased in atrophic gastric mucosae with reduced NKX6.3 expression. B and C: Expression levels of *ApoE* and *Bace1* mRNAs were significantly higher in gastric mucosae with atrophy (B), showing inverse correlations with NKX6.3 expression (*P \<* 0.0001, C). Shown are the means ± SEM from three experiments. Superscript letter represents significant difference (^a^*P \<* 0.0001, ^b^*P \<* 0.0001 and ^c^*P \<* 0.0001). D: In Aβ42 enzyme-linked immunosorbent assay, concentrations of aggregated Aβ were significantly increased in gastric mucosae with (W/) atrophy (1.20 ± 0.60 μg/mL) compared to without (W/O) atrophy (0.09 ± 0.09 μg/mL). Shown are the means ± SEM from three experiments. Superscript letter represents significant difference (^d^*P \<* 0.0001). E: Western blot analysis showing decreased expression of NKX6.3 and increased expression of ApoE, Aβ oligomer, Bace1, and cleaved caspase-3 proteins in CagA transfected HFE-145 cells. In addition, CagA significantly increased concentrations of aggregated Aβ in both cell lysate and culture media. Shown are the means ± SEM from three experiments. Superscript letter represents significant difference (^e^*P \<* 0.005 and ^f^*P \<* 0.0001). F: Knock-down of Aβ inhibited CagA-induced floating cells populations. Shown are the means ± SEM from three experiments. Superscript letter represents significant difference (^g^*P \<* 0.005 and ^h^*P \<* 0.0001). G: Immunofluorescence analysis showing expression of Aβ oligomer and Bace1 only in gastric mucosae with atrophy, but not in gastric mucosa without atrophy. Right panel is a higher magnification of the Aβ oligomer and Bace1 in the inlet in gastric mucosae with atrophy. ApoE: Apolipoprotein E; Aβ: Amyloid β; Bace1: β-secretase 1; W/: With atrophy; W/O: Without atrophy.](WJG-25-330-g003){#F3}

Aβ induces cell death in gastric epithelial cells
-------------------------------------------------

Next, to investigate whether oligomeric forms of Aβ were associated with gastric mucosal atrophy, we analyzed cell viability of gastric epithelial cells after treatment with rAβ 1-42. Because we found 1.18 ± 0.57 μg/mL of aggregated Aβ peptide in gastric mucosae with atrophy (Figure [3](#F3){ref-type="fig"}), we treated HFE-145^shCtrl^ and HFE-145^shNKX6.3^ cells with 1 μg/mL of rAβ for 4 d. As shown in Figure [4A](#F4){ref-type="fig"}, treatment with rAβ 1-42 produced oligomeric forms of Aβ only in HFE-145^shNKX6.3^ cells, but not in HFE-145^shCtrl^ cells (Figure [4A](#F4){ref-type="fig"}). In addition, recombinant GKN1 (rGKN1) partially reduced expression of Aβ oligomers (Figure [4A](#F4){ref-type="fig"}). In HFE-145^shNKX6.3^ cells, treatment with rAβ 1-42 significantly reduced cell viability but markedly increased floating cell population in HFE-145^shNKX6.3^ cells (Figure [4B](#F4){ref-type="fig"} and C). Notably, rGKN1 partially revoked the effect of rAβ on cell viability (Figure [4D](#F4){ref-type="fig"}). However, treatment with rAβ 1-42 did not affect cell viability of HFE-145^shCtrl^ cells (Figure [4B](#F4){ref-type="fig"}). These results suggest that Aβ oligomerization prompted by NKX6.3 depletion may induce cell death in gastric epithelial cells.

![Amyloid β induces cell death in gastric epithelial cells. A: Treatment with recombinant amyloid β (rAβ) 1-42 produced oligomeric forms of Aβ in HFE-145^shNKX6.3^ cells, but not in HFE-145^shCtrl^ cells. Recombinant gastrokine 1 (rGKN1) partially reduced expression of Aβ oligomers. B: Treatment with rAβ 1-42 did not affect viability of HFE-145^shCtrl^ cells, although it significantly decreased viability of HFE-145^shNKX6.3^ cells in a time dependent manner. Shown are the means ± SEM from three experiments. Superscript letter represents significant difference (^a^*P \<* 0.05, ^b^*P \<* 0.005 and ^c^*P \<* 0.0001). C: Floating cell population was markedly increased in HFE-145^shNKX6.3^ cells treated with rAβ 1-42. Shown are the means ± SEM from three experiments. Superscript letter represents significant difference (^d^*P \<* 0.001). D: In HFE-145^shNKX6.3^ cells, treatment with rAβ 1-42 for 72 hrs decreased cell viability while treatment with rGKN1 revoked the effect of rAβ on cell viability. Shown are the means ± SEM from three experiments. Superscript letter represents significant difference (^e^*P \<* 0.05 and ^f^*P \<* 0.005). rAβ: Recombinant amyloid β; rGKN1: Recombinant gastrokine 1; Aβ: Amyloid β.](WJG-25-330-g004){#F4}

NKX6.3 depletion induces inflammatory cytokine expression in gastric epithelial cells
-------------------------------------------------------------------------------------

It is known that Aβ accumulation in human nerve cells leads to synthesis of proinflammatory cytokines and activation of inflammatory pathways\[[@B30]\]. Thus, we further examined the expression of inflammatory markers including IL-1β, -6, -8, and COX-2 by real-time RT-PCR. Expectedly, NKX6.3 depletion in HFE-145^shNKX6.3^ cells dramatically increased the expression of these inflammatory cytokines and COX-2 (Figure [5A](#F5){ref-type="fig"}). In HFE-145^shNKX6.3^ cells, silencing of ApoE with *siApoE* markedly inhibited oligomerization and aggregation of Aβ peptide. It also suppressed expression of NF-κB p-p65 and inflammatory cytokines (Figure [5B](#F5){ref-type="fig"} and C). This suggests that ApoE plays an important role in Aβ oligomerization and synthesis of inflammatory cytokines.

![NKX6.3 depletion induces inflammatory cytokine expression in gastric epithelial cells. A: NKX6.3 depletion in HFE-145^shNKX6.3^ cells dramatically increased expression of inflammatory cytokines, including interleukin (IL)-1β, IL-6, and IL-8, and cyclooxygenase-2. Shown are the means ± SEM from three experiments. Superscript letter represents significant difference (^a^*P \<* 0.005 and ^b^*P \<* 0.001). B and C: In HFE-145^shNKX6.3^ cells, silencing of apolipoprotein E (ApoE) with *siApoE* markedly inhibited oligomerization and aggregation of amyloid β and expression of nuclear factor kappa B p-p65 and inflammatory cytokines. Shown are the means ± SEM from three experiments. Superscript letter represents significant difference (^c^*P \<* 0.05, ^d^*P \<* 0.005 and ^e^*P \<* 0.0001). IL: Interleukin; COX-2: Cyclooxygenase-2; ApoE: Apolipoprotein E; Aβ: Amyloid β; NF-κB: Nuclear factor kappa B.](WJG-25-330-g005){#F5}

DISCUSSION
==========

Inflammatory disorders have been well recognized as key risk factor for many types of cancers. Stages of precancerous cascade for gastric adenocarcinoma are a series of histologically discernible changes in gastric mucosa with the following sequence: non-atrophic gastritis, multifocal atrophic gastritis, intestinal metaplasia (IM), and dysplasia\[[@B31]\]. *H. pylori* infection has been identified as the causative agent of chronic gastric inflammation, such as atrophic gastritis and metaplastic gastritis\[[@B32]\]. However, molecular mechanisms underlying gastric mucosal atrophy still remain to be determined for the prevention and early diagnosis of gastric cancer. Since intracellular generation of the Aβ protein is known to lead to neuronal death\[[@B19]\] while NKX6.3 expression is confined to the gut and caudal hindbrain\[[@B33]\]. Thus, we hypothesized that NKX6.3 could protect gastric mucosa from atrophic changes by inhibiting Aβ accumulation.

We first examined whether NKX6.3 was involved in proliferation and death of gastric mucosa. As shown in Figure [1A](#F1){ref-type="fig"}, NKX6.3 depletion in HFE-145^shNKX6.3^ cells significantly increased proportions of both adherent and floating cells. In addition, increased caspase 3/7 activity was found in floating HFE-145^shNKX6.3^ cells (Figure [1B](#F1){ref-type="fig"}). In Western blot analysis, NKX6.3 did not affect expression of apoptosis markers, including PARP, caspase-3, or caspase-9 in adherent HFE-145^shNKX6.3^ cells, but NKX6.3 depletion induced expression of these apoptotic markers (Figure [1C](#F1){ref-type="fig"}), providing an intriguing scenario where NKX6.3 might be a key regulator of gastric mucosal homeostasis by inhibiting both cell proliferation and death. Here, we focused on the inhibitory activity of NKX6.3 on death of gastric mucosal epithelial cells.

In general, regulation of proteolysis plays a crucial role in many processes of development, cell proliferation and death. Dysregulation of proteolytic system can destroy cellular homeostasis by accumulation of specific proteins, thus contributing to disease pathogenesis. Amyloid aggregates have been found to be associated with disruption of several cellular functions, including mitochondrial activity\[[@B34]\], oxidative stress\[[@B35],[@B36]\], and apoptosis\[[@B37]\]. Aβ acts as a neurotoxin that directly induces oxidative stress whereas RAGE mediates Aβ-induced oxidative stress and inflammatory response. Increased expression of RAGE has been implicated in the pathogenesis of neuronal dysfunction and death\[[@B15]\]. In the present study, we hypothesized that Aβ peptide accumulation caused by NKX6.3 depletion could induce gastric epithelial cell death which subsequently could contribute to gastric mucosal atrophy. Interestingly, depletion of NKX6.3 induced Aβ peptide accumulation in the cytoplasm of HFE-145^shNKX6.3^ cells and increased expression of Aβ in cell lysate and culture medium (Figure [2](#F2){ref-type="fig"}). These results suggest that NKX6.3 may inhibit accumulation and oligomerization of Aβ peptide in gastric epithelial cells.

Cleavage of APP by Bace1 produces a large soluble ectodomain form and a membrane-bound 99-amino acid C-terminal fragment. Subsequently, the γ-secretase protein complex will cleave the C-terminus of C99 to produce a 40- to 42-amino acid Aβ-peptide\[[@B38]\]. After sequential cleavage of APP by β- and γ-secretases\[[@B38],[@B39]\], Aβ monomer can aggregate to form oligomers, protofibrils, and fibrils that deposit as amyloid plaque\[[@B40]\]. RAGE and HMGB1 are involved in activating NF-κB\[[@B41]\], and the interaction of RAGE and HMGB1 can be lined to necrosis and a proinflammatory response in cells\[[@B42]\]. Here, we found that NKX6.3 depletion induced expression of ApoE, APP, Aβ, Bace1, LDLR, NCT, HMGB1, and RAGE proteins in HFE-145^shNKX6.3^ cells (Figure [2A](#F2){ref-type="fig"}). In addition, NKX6.3 inhibited the γ-secretase complex assembly (Figure [2B](#F2){ref-type="fig"}) and down-regulated expression of the *APOE* and *Bace1* genes by acting as a transcriptional repressor (Figure [2D](#F2){ref-type="fig"} and E). In gastric mucosae with atrophy, oligomeric forms of Aβ and Bace1 were detected by immunofluorescent and Western blot analyses (Figure [3A](#F3){ref-type="fig"} and G), and the increased expression of *APOE* and *Bace1* was inversely correlated with NKX6.3 expression (Figure [3B](#F3){ref-type="fig"} and C). Interestingly, expression of Aβ oligomer, Bace1, ApoE, cleaved caspase-3, and *H. pylori* CagA was closely associated with gastric mucosal atrophy and inversely correlated with NKX6.3 expression (*P* \< 0.0001, Table [1](#T1){ref-type="table"}). Furthermore, Aβ peptide concentrations were significantly higher in gastric mucosae with atrophy (1.18 ± 0.57 μg/ml) than those in gastric mucosae without atrophy (0.07 ± 0.04 μg/ml; Figure [3D](#F3){ref-type="fig"}). In HFE-145 cells, *H. pylori* CagA increased the expression of ApoE, Bace1, and cleaved caspase-3 and induced oligomerization and aggregation of Aβ peptide (Figure [3E](#F3){ref-type="fig"}). Notably, *siAβ* markedly inhibited CagA effect of cell viability (Figure [3F](#F3){ref-type="fig"}), indicating that Aβ be involved in CagA-induced cell death in non-neoplastic gastric epithelial cells. Taken together, these results suggest that NKX6.3 may prevent gastric mucosal atrophy by regulating Aβ degradation or clearance pathway.

###### 

Protein expression of amyloid β oligomer, β-secretase 1, apolipoprotein E, cleaved caspase-3, and *Helicobacter pylori* CagA was significantly associated with gastric mucosal atrophy and inversely correlated with NKX6.3 expression

                  **Atrophy**   **NKX6.3**   **Aβ oligomer**   **Bace1**   **ApoE**   **Cleaved Casp3**                                                                            
  --------------- ------------- ------------ ----------------- ----------- ---------- ------------------- -------- ---- ---- -------- ---- --- -------- ---- --- -------- ---- --- --------
  NKX6.3          \+            3            33                0.0001                                                                                                              
  \-              15            4                                                                                                                                                  
  Aβ oligomer     \+            17           2                 0.0001      3          16                  0.0001                                                                   
  \-              1             35                             33          3                                                                                                       
  Bace1           \+            16           5                 0.0001      2          19                  0.0001   18   3    0.0001                                                
  \-              2             32                             34          0                              1        33                                                              
  ApoE            \+            18           5                 0.0001      4          19                  0.0001   19   4    0.0001   21   2   0.0001                              
  \-              0             32                             32          0                              0        32        0        32                                           
  Cleaved Casp3   \+            16           8                 0.0001      5          19                  0.0001   19   5    0.0001   21   3   0.0001   22   2   0.0001            
  \-              2             29                             31          0                              0        31        0        31       1        30                         
  CagA            \+            14           12                0.0041      9          17                  0.0001   16   10   0.0002   19   7   0.0001   19   7   0.0001   21   5   0.0001
  \-              4             25                             27          2                              3        26        2        27       4        25       3        26       

Aβ: Amyloid β; ApoE: Apolipoprotein E; Bace1: β-secretase 1; Casp3: Caspase-3.

Recent studies have shown that soluble oligomeric species of Aβ have direct adverse effects, whereas fibrillar or monomeric Aβ seems to be less harmful *in vitro* and in animal models\[[@B43]-[@B45]\]. Soluble Aβ oligomers can produce cognitive deficits in the absence of plaques\[[@B46]\] while blocking the Aβ oligomerization can protect cells from toxicity\[[@B47]\], suggesting that oligomerization of Aβ peptide may be a key event in the development of cerebral atrophy. In addition, it has been reported that Aβ oligomers can induce inflammation through RAGE receptor\[[@B48]\] and inhibition of RAGE has therapeutic potential to prevent Aβ-induced inflammatory damage to the brain\[[@B49]\]. NF-κB, a key regulator of inflammation, is activated by Aβ which then transcriptionally regulates IL-6 and IL-8\[[@B50]\]. HMGB1 binds to RAGE receptor to activate a multitude of proinflammatory genes\[[@B51]\]. Recent studies have shown that GKN1 can prevent amyloid aggregation and fibril formation and block the access of γ-secretase to APP *in vitro*\[[@B26],[@B52]\]. Experimental studies showed that partial atrophy of the gastric mucosa in aging rat is not related to the inflammation and gastric mucosa of aging rat has increased susceptibility to injury by a variety of damaging agents\[[@B53],[@B54]\]. Previously, we have reported that NKX6.3 transcriptionally suppresses reactive oxygen production and NF-κB activation which is required for expression of IL-6 and IL-8\[[@B55]\]. Here, we found that treatment with rAβ 1-42 produced oligomeric forms of Aβ and significantly decreased cell viability of HFE-145^shNKX6.3^ cells (Figure [4A](#F4){ref-type="fig"} and B). In addition, NKX6.3 depletion dramatically increased expression of inflammatory cytokines and COX-2 by upregulating ApoE (Figure [5](#F5){ref-type="fig"}). These results are consistent with our previous report showing that NKX6.3 transcriptionally suppresses reactive oxygen production and NF-κB activation which is required for expression of IL-6 and IL-8\[[@B55]\]. Thus, upregulation of ApoE prompted by NKX6.3 depletion might play an important role in Aβ oligomerization and gastric mucosal inflammation. These findings suggest that depletion of NKX6.3 may account for increased susceptibility of gastric epithelial cells to Aβ-induced cytotoxicity and contribute to gastric mucosal atrophy.

In conclusion, NKX6.3 is a key regulator of gastric mucosal homeostasis *via* inhibiting both cell proliferation and apoptotic cell death. Aβ accumulation was detected in the cytoplasm of HFE-145^shNKX6.3^ cells and gastric mucosae with atrophy. NKX6.3 inhibited accumulation and oligomerization of Aβ peptide in gastric epithelial cells by regulating Aβ degradation or clearance pathways. Finally, NKX6.3 suppressed gastric mucosal inflammation by modulating ApoE-induced NF-κB and expression of cytokines. These observations provide evidence that NKX6.3 can restrain gastric mucosal atrophy by regulating Aβ accumulation and inflammatory reaction in gastric epithelial cells (Figure [6](#F6){ref-type="fig"}).

![Schematic model of the role of NKX6.3 in gastric mucosal atrophy. In gastric mucosal cells, NKX6.3 prevents gastric mucosal atrophy by regulating amyloid β (Aβ) peptide accumulation and oligomerization through inhibiting the γ-secretase complex formation and the expression of apolipoprotein E (ApoE), and β-secretase 1. In addition, NKX6.3 suppresses gastric mucosal inflammation by modulating ApoE-induced nuclear factor kappa B activity and expression of cytokines. Aβ: Amyloid β; ApoE: Apolipoprotein E; Bace1: β-secretase 1; NF-κB: Nuclear factor kappa B.](WJG-25-330-g006){#F6}

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

Atrophic gastritis is characterized by loss of appropriate glands and considered as a precancerous condition of gastric cancer. However, little is known about the molecular mechanism underlying gastric mucosal atrophy. NKX6.3 plays a key role in the maintaining gastric epithelial homeostasis. Amyloid β (Aβ) acts as a neurotoxin that directly induces oxidative stress and receptor for advanced glycation end products (RAGE) mediates Aβ-induced oxidative stress and inflammatory response. Increased expression of RAGE has been implicated in the pathogenesis of neuronal cell death. Interestingly, gastrokine 1, a downstream target of NKX6.3, interacts with amyloid precursor protein (APP) and inhibits polymerization of Aβ.

Research motivation
-------------------

A better understanding of molecular mechanism underlying gastric mucosal atrophy could protect against gastric mucosal atrophy and gastric carcinogenesis.

Research objectives
-------------------

To investigate whether NKX6.3 might play a critical role in the development of gastric mucosal atrophy by regulating Aβ production.

Research methods
----------------

We examined whether NKX6.3 depletion induces cell death by cell count and Western blot assay. Production and mechanism of Aβ oligomer were analyzed by enzyme-linked immunosorbent assay, Western blot, immunoprecipitation, real-time quantitative polymerase chain reaction and immunofluorescence analysis in HFE-145 non-neoplastic gastric epithelial cells and gastric mucosal tissues. We further validated the correlation between expression of NKX6.3, *Helicobacter pylori* CagA, Aβ oligomer, apolipoprotein E (ApoE), and β-secretase 1 (Bace1) in gastric mucosae.

Research results
----------------

We found that NKX6.3 depletion increased floating cell populations in HFE-145 cells and induced production of Aβ peptide oligomers. In addition, NKX6.3 depletion increased expression of APP, Aβ, and RAGE proteins. In gastric mucosae with atrophy, expression of Aβ peptide oligomer, *ApoE*, and *Bace1* was detected and inversely correlated with NKX6.3 expression. Treatment with rAβ 1-42 produced oligomeric forms of Aβ and significantly decreased cell viability only in HFE-145^shNKX6.3^ cells. Furthermore, NKX6.3 depletion in HFE-145^shNKX6.3^ cells increased expression of inflammatory cytokines and cyclooxygenase-2.

Research conclusions
--------------------

These data strongly suggest that NKX6.3 inhibit gastric mucosal atrophy by regulating Aβ accumulation and inflammatory reaction in gastric epithelial cells.

Research perspectives
---------------------

Additional studies are needed to validate the results obtained. Identification of molecular mechanism underlying gastric mucosal atrophy could contribute to the prevention of atrophic gastritis and gastric cancer.
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